Scientific paper Archives - IMI AMR Accelerator

17/04/24 ERA4TB – Evaluation of critical parameters in the hollow-fibre system for tuberculosis: A case study of moxifloxacin

16/04/24 ERA4TB – A systematic review of economic evaluations of pharmacological treatments for active tuberculosis

PrIMAVeRa – Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review

PrIMAVeRa – Synthesizing pathogen- and infection-specific estimates of the burden of antimicrobial resistance in Europe for health-technology assessment: gaps, heterogeneity, and bias

ERA4TB – Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units

PrIMAVeRa – A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe

ERA4TB – Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium

UNITE4TB – Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

UNITE4TB – Tuberculosis: current challenges and beyond

PrIMAVeRa – Targeted mupirocin-based decolonization for Staphylococcus aureus carriers and the subsequent risk of mupirocin resistance in haemodialysis patients: a longitudinal study over 20 years